Trends in Dupilumab Utilization for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
M.J.C. serves as a consultant for 3-D Matrix (Newton, MA), Acclarent (Irving, CA), Medtronic (Jacksonville, FL), Neurent (Braintee, MA), and Lynx MD (Palo Alto, CA). A.U.L. serves as a consultant for AstraZeneca (Cambridge, UK), GlaxoSmithKline (Maharashtra, India), (Lyra Therapeutics (Watertown, MA), Medtronic (Dublin, IE), Neurent Medical (Galway, IE), Sanofi (Paris, France), Sound Health Systems (Los Altos, CA), and Stryker (Kalamazoo, MI). A.U.L. serves on the scientific advisory board for Maxwell Biosciences (Austin, TX). W.C.Y. serves as a consultant for Acclarent Inc. (Irving, CA), Aerin Medical (Mountain View, CA), and as a Speaker for Optinose Inc. (Yardley, PA). No disclosures for DX and JT.
Authors
- Daniel Xiao (ORCID: https://orcid.org/0000-0002-3196-3884)
- Amber Luong (ORCID: https://orcid.org/0000-0001-6078-8010)
- Jason Talmadge (ORCID: https://orcid.org/0000-0002-4652-9087)
- William C. Yao (ORCID: https://orcid.org/0000-0002-9845-2165)
- Martin J. Citardi (ORCID: https://orcid.org/0000-0002-1155-9235)
Institutions
- Brown Foundation (US)
- Nebraska Cancer Specialists (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1002/alr.23508
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00